The case for supporting inpatient glycemic control programs now: The evidence and beyond

Journal of Hospital Medicine

Volumn 3, Issue SUPPL 5, 2008, Pages

  Braithwaite, Susan S ^a   Magee, Michelle ^b,c   Sharretts, John M ^c   Schnipper, Jeffrey L ^d,e   Amin, Alpesh ^f   Maynard, Gregory ^g  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MedStar Diabetes Institute   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; INSULIN;

DIABETES MELLITUS; EVIDENCE BASED MEDICINE; GLUCOSE BLOOD LEVEL; HOSPITAL; HOSPITAL PATIENT; HUMAN; HYPERGLYCEMIA; INFLAMMATION; PATHOPHYSIOLOGY; PATIENT CARE; PRACTICE GUIDELINE; QUALITY CONTROL; REVIEW; STANDARD; TOTAL QUALITY MANAGEMENT;

BENCHMARKING; BLOOD GLUCOSE; DIABETES COMPLICATIONS; EVIDENCE-BASED MEDICINE; HEMOGLOBIN A, GLYCOSYLATED; HOSPITALS; HUMANS; HYPERGLYCEMIA; INFLAMMATION; INPATIENTS; INSULIN; PATIENT CARE TEAM; PRACTICE GUIDELINES AS TOPIC; TOTAL QUALITY MANAGEMENT;

EID: 56149104853     PISSN: 15535592     EISSN: 15535606     Source Type: Journal    
DOI: 10.1002/jhm.350     Document Type: Review

References (85)

1. American College of Endocrinology and American Diabetes Association Consensus Statement on Inpatient Diabetes and Glycemic Control: A call to action. Diabetes Care. 2006; 29: 1955-1962.
2. Standards of medical care in diabetes--2008. Diabetes Care. 2008; 31( Suppl 1): S12-S54.
3. Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002. Diabetes Care. 2006; 29: 1263-1268.
4. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2005. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2005. Available at: http://www.cdc.gov/diabetes/pubs/factsheet05.htm. Accessed September 2007.
5. Hogan P, Dall T, Nikolov P. Economic costs of diabetes in the US in 2002. Diabetes Care. 2003; 26: 917-932.
6. Queale WS, Seidler AJ, Brancati FL. Glycemic control and sliding scale insulin use in medical inpatients with diabetes mellitus. Arch Intern Med. 1997; 157: 545-552.
7. Metchick LN, Petit WAJr, Inzucchi SE. Inpatient management of diabetes mellitus. Am J Med. 2002; 113: 317-323.
8. Clement S, Braithwaite SS, Magee MF, et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 2004; 27: 553-591.
9. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006; 354: 449-461.
10. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001; 345: 1359-1367.
11. Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc. 2003; 78: 1471-1478.
12. Levetan CS, Passaro M, Jablonski K, Kass M, Ratner RE. Unrecognized diabetes among hospitalized patients. Diabetes Care. 1998; 21: 246-249.
13. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002; 87: 978-982.
14. United States Department of Health and Human Services Agency for Healthcare Research and Quality. 2007. Available at: http://hcupnet.ahrq.gov. Accessed December 2007.
15. Norhammar A, Tenerz A, Nilsson G, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet. 2002; 359: 2140-2144.
16. Zarich SW. Mechanism by which hyperglycemia plays a role in the setting of acute cardiovascular illness. Rev Cardiovasc Med. 2006; 7( Suppl 2): S35-S43.
17. Bauters C, Ennezat PV, Tricot O, Lauwerier B, Lallemant R, Saadouni H, et al. Stress hyperglycaemia is an independent predictor of left ventricular remodelling after first anterior myocardial infarction in non-diabetic patients. Eur Heart J. 2007; 28: 546-552.
18. Zarich SW, Nesto RW. Implications and treatment of acute hyperglycemia in the setting of acute myocardial infarction. Circulation. 2007; 115: e436-e439.
19. Dandona P, Mohanty P, Chaudhuri A, Garg R, Aljada A. Insulin infusion in acute illness. J Clin Invest. 2005; 115: 2069-2072.
20. Hansen T, Thiel S, Wouters P, Christiansen J, Van den Berghe B. Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-gind lectin levels. J Clin Endocrinol Metab. 2003; 88: 1082-1088.
21. Vanhorebeek I, De Vos R, Mesotten D, Wouters PJ, De Wolf-Peeters C, Van den Berghe G. Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients. Lancet. 2005; 365: 53-59.
22. Langouche L, Vanhorebeek I, Vlasselaers D, et al. Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest. 2005; 115: 2277-2286.
23. Ainla T, Baburin A, Teesalu R, Rahu M. The association between hyperglycaemia on admission and 180-day mortality in acute myocardial infarction patients with and without diabetes. Diabet Med. 2005; 22: 1321-1325.
24. Kosiborod M, Rathore SS, Inzucchi SE, et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation. 2005; 111: 3078-3086.
25. Malmberg K, Norhammar A, Wedel H, Ryden L. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation. 1999; 99: 2626-2632.
26. Capes S, Hunt D, Malmberg K, Gerstein H. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000; 355: 773-778.
27. Bruno A, Williams LS, Kent TA. How important is hyperglycemia during acute brain infarction? Neurologist. 2004; 10: 195-200.
28. Capes S, Hunt D, Malmberg K, Pathak P, Gerstein H. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke. 2001; 32: 2426-2432.
29. Golden SH, Peart-Vigilance C, Kao WHL, Brancati F. Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care. 1999; 22: 1408-1414.
30. Pomposelli JJ, Baxter JK, Babineau TJ, et al. Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. JPEN J Parenter Enteral Nutr. 1998; 22: 77-81.
31. McAlister FA, Majumdar SR, Blitz S, Rowe BH, Romney J, Marrie TJ. The relation between hyperglycemia and outcomes in 2, 471 patients admitted to the hospital with community-acquired pneumonia. Diabetes Care. 2005; 28: 810-815.
32. Thomas M, Mathew T, Russ G, Rao M, Moran J. Early peri-operative glycaemic control and allograft rejection in patients with diabetes mellitus: a pilot study. Transplantation. 2001; 72: 1321-1324.
33. Weiser MA, Cabanillas ME, Konopleva M, et al. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen. Cancer. 2004; 100: 1179-1185.
34. Muhlestein JB, Anderson JL, Horne BD, et al. Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention. Am Heart J. 2003; 146: 351-358.
35. Furnary AP, Wu Y, Bookin SO. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland diabetic project. Endocr Pract. 2004; 10( Suppl 2): 21-33.
36. Gandhi GY, Nuttall GA, Abel MD, et al. Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients. Mayo Clin Proc. 2005; 80: 862-866.
37. Latham R, Lancaster AD, Covington JF, Pirolo JS, Thomas CS. The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients. Infect Control Hosp Epidemiol. 2001; 22: 607-612.
38. Zerr KJ, Furnary AP, Grunkemeier GL. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg. 1997; 63: 356-361.
39. The Portland Protocol. Available at: http://www.providence.org/oregon/grograms_and_services/heart/portlandpro tocol/. Accessed September 2007.
40. Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc. 2004; 79: 992-1000.
41. Van den Berghe G, Wilmer A, Milants I, et al. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes. 2006; 55: 3151-3159.
42. Vanhorebeek I, Langouche L, Van den Berghe G. Tight blood glucose control with insulin in the ICU: facts and controversies. Chest. 2007; 132: 268-278.
43. Grey NJ, Perdrizet GA. Reduction of nosocomial infections in the surgical intensive-care unit by strict glycemic control. Endocr Pract. 2004; 10( Suppl 2): 46-52.
44. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008; 358: 125-139.
45. Devos P, Preiser JC. Current controversies around tight glucose control in critically ill patients. Curr Opin Clin Nutr Metab Care. 2007; 10: 206-209.
46. Ahmann A, Hellman R, Larsen K, Maynard G. Designing and implementing insulin infusion protocols and order sets. J Hosp Med. 2008; 3(5): S42-S54.
47. Umpierrez GE, Smiley D, Zisman A, Prieto LM, Palacio A, Ceron M, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care. 2007; 30: 2181-2186.
48. Society of Hospital Medicine. Glycemic control resource room. Available at: http://www.hospitalmedicine.org/ResourceRoomRedesign/GlycemicControl.cfm . Accessed November 2007.
49. Society of Hospital Medicine. Workbook for improvement: improving glycemic control, preventing hypoglycemia, and optimizing care of the inpatient with hyperglycemia and diabetes. Available at: http://www.hospitalmedicine.org/ResourceRoomRedesign/pdf/GC_Workbook.pdf . Accessed November 2007.
50. Garber AJ, Moghissi ES, Bransome EDJr, et al. American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract. 2004; 10: 77-82.
51. Maynard G, Lee JH, Phillips G, Fink MA, Renvall M. Improved inpatient use of basal insulin, reduced hypoglycemia, and improved glycemic control: effect of structured subcutaneous insulin orders and an insulin management algorithm. J Hosp Med. 2008. In press.
52. American Association of Clinical Endocrinologists Inpatient Glycemic Control Resource Center. 2007. Available at: http://resources.aace.com/index.asp. Accessed December 2007.
53. American Heart Association. Get With the Guidelines. Available at: http://www.americanheart.org/getwiththeguidelines. Accessed November 2007.
54. Joint Commission. Disease Specific-Care Certification. Available at:http://www.jointcommission.org/CertificationPrograms. Accessed November 2007.
55. The Joint Commission Disease-Specific Certification Program. Range JE. Oncology issues. July/August 2007: 40-41.
56. Anonymous. The Diabetes Control and Complications Trial Research Group (DCCT). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329: 977-986.
57. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type, 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998; 352: 837-853.
58. Gaede P, Vedel P, Parving H-H, Pedersen OU. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet. 1999; 353: 617-622.
59. Greci LS, Kailasam M, Malkani S, et al. Utility of HbA1c levels for diabetes case finding in hospitalized patients with hyperglycemia. Diabetes Care. 2003; 26: 1064-1068.
60. Baldwin D, Villanueva G, McNutt R, Bhatnagar S. Eliminating inpatient sliding-scale insulin: a reeducation project with medical house staff. Diabetes Care. 2005; 28: 1008-1011.
61. Warshaw HS, Bolderman KM. Advanced carbohydrate counting. In: Practical Carbohydrate Counting: A How-to-Teach Guide for Health Professionals. Alexandria, VA: American Diabetes Association; 2001: 26-28.
62. Pastors JG, Warshaw H, Daly A, Franz M, Kulkarni K. The evidence for the effectiveness of medical nutrition therapy in diabetes management. Diabetes Care. 2002; 25: 608-613.
63. Boucher JL, Swift CS, Franz MJ, et al. Inpatient management of diabetes and hyperglycemia: implications for nutrition practice and the food and nutrition professional. J Am Diet Assoc. 2007; 107: 105-111.
64. Braithwaite SS. The transition from insulin infusions to long-term diabetes therapy: the argument for insulin analogs. Semin Thorac Cardiovasc Surg. 2006; 18: 366-378.
65. O'Malley. Transitions paper. J Hosp Med. 2008.
66. Schnipper JL, Barsky EE, Shaykevich S, Fitzmaurice G, Pendergrass ML. Inpatient management of diabetes and hyperglycemia among general medicine patients at a large teaching hospital. J Hosp Med. 2006; 1: 145-150.
67. Phillips LS, Branch WT, Cook CB, et al. Clinical inertia. Ann Intern Med. 2001; 135: 825-834.
68. Cook CB, Castro JC, Schmidt RE, et al. Diabetes care in hospitalized noncritically ill patients: more evidence for clinical inertia and negative therapeutic momentum. J Hosp Med. 2007; 2: 203-211.
69. University HealthSystem Consortium. Glycemic control 2005 findings and conclusions. Presented at: Glycemic Control 2005 Knowledge Transfer Meeting; 2005 August 19, 2005; Chicago, IL.
70. Umpierrez G, Maynard G. Glycemic chaos (not glycemic control) still the rule for inpatient care: how do we stop the insanity? J Hosp Med. 2006; 1: 141-144.
71. Golightly LK, Jones MA, Hamamura DH, Stolpman NM, McDermott MT. Management of diabetes mellitus in hospitalized patients: efficiency and effectiveness of sliding-scale insulin therapy. Pharmacotherapy. 2006; 26: 1421-1432.
72. Varghese P, Gleason V, Sorokin R, Senholzi C, Jabbour S, Gottlieb JE. Hypoglycemia in hospitalized patients treated with antihyperglycemic agents. J Hosp Med. 2007; 2: 234-240.
73. Fischer KF, Lees JA, Newman JH. Hypoglycemia in hospitalized patients. N Engl J Med. 1986; 315: 1245-1250.
74. Vriesendorp TM, van Santen S, DeVries JH, et al. Predisposing factors for hypoglycemia in the intensive care unit. Crit Care Med. 2006; 34: 96-101.
75. Svensson AM, McGuire DK, Abrahamsson P, Dellborg M. Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events. Eur Heart J. 2005; 26: 1255-1261.
76. Pinto DS, Skolnick AH, Kirtane AJ, et al. U-shaped relationship of blood glucose with adverse outcomes among patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2005; 46: 178-180.
77. Eshaghian S, Horwich TB, Fonarow GC. An unexpected inverse relationship between HbA1c levels and mortality in patients with diabetes and advanced systolic heart failure. Am Heart J. 2006; 151: 91.
78. Kosiborod M, Inzucchi SE, Krumholz HM, et al. Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk. Circulation. 2008; 117: 1018-1027.
79. Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabetes Care. 2003; 26: 1902-1912.
80. Bhatia A, Cadman B, Mackenzie I. Hypoglycemia and cardiac arrest in a critically ill patient on strict glycemic control. Anesth Analg. 2006; 102: 549-551.
81. Scalea TM, Bochicchio GV, Bochicchio KM, Johnson SB, Joshi M, Pyle A. Tight glycemic control in critically injured trauma patients. Ann Surg. 2007; 246: 605-610; discussion 10-12.
82. Krinsley JS, Grover A. Severe hypoglycemia in critically ill patients: risk factors and outcomes. Crit Care Med. 2007; 35: 2262-2267.
83. Garg R, Bhutani H, Jarry A, Pendergrass M. Provider response to insulin-induced hypoglycemia in hospitalized patients. J Hosp Med. 2007; 2: 258-260.
84. Newton CA, Young S. Financial implications of glycemic control: results of an inpatient diabetes management program. Endocr Pract. 2006; 12( Suppl 3): 43-48.
85. Levetan CS, Salas JR, Wilets IF, Zumoff B. Impact of endocrine and diabetes team consultation on hospital length of stay for patients with diabetes. Am J Med. 1995; 99: 22-28.